Affimed N.V. DPO Ratio 2011-2026 | AFMD

Annual DPO Ratio Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	2.52 K	3.02 K	1.53 K	1.89 K	1.8 K	1.65 K	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
3.02 K	1.53 K	2.07 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 21.41	0.21 %	$ 1 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Clearside Biomedical CLSD	1.67 K	-	-	$ 25.3 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	168	$ 1.53	4.08 %	$ 393 M	USA
Evogene Ltd. EVGN	62.6	$ 0.82	0.51 %	$ 27.9 M	Israel
Aquestive Therapeutics AQST	395	$ 4.15	-0.95 %	$ 444 M	USA
Arcutis Biotherapeutics ARQT	133	$ 25.2	4.48 %	$ 3.21 B	USA
Chimerix CMRX	2.38 K	-	-	$ 756 M	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	4.06 K	$ 33.28	2.12 %	$ 2.21 B	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.5	2.04 %	$ 399 M	Britain
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain